Etoposide and Hepatitis cholestatic - a phase IV clinical study of FDA data

Summary:

Hepatitis cholestatic is reported as a side effect among people who take Etoposide (etoposide), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Hepatitis cholestatic when taking Etoposide. It is created by eHealthMe based on reports of 77,756 people who have side effects when taking Etoposide from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Hepatitis cholestatic?

Hepatitis cholestatic (flow of bile from the liver is slowed or blocked) is found to be associated with 546 drugs and 824 conditions by eHealthMe. Check the latest studies of Hepatitis cholestatic.

On Jul, 06, 2026

77,756 people reported to have side effects when taking Etoposide.
Among them, 73 people (0.09%) have Hepatitis cholestatic.

Could Etoposide cause Hepatitis cholestatic?

Among these 73 people:

How long have people been on Etoposide when they have Hepatitis cholestatic? *

What is the gender of people who have Hepatitis cholestatic when taking Etoposide? *

female: 24.24 %
male: 75.76 %

What is the age of people who have Hepatitis cholestatic when taking Etoposide? *

What are other drugs people take besides Etoposide? *

What are other side effects people have besides Hepatitis cholestatic? *

Headache (pain in head): 15 people, 20.55%
High Blood Pressure: 14 people, 19.18%
Neutropenic Colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition): 14 people, 19.18%
Sepsis (a severe blood infection that can lead to organ failure and death): 14 people, 19.18%
Hepatic Fibrosis (scarring process that represents the liver's response to injury): 13 people, 17.81%
Intestinal Obstruction: 10 people, 13.70%
Acute Hepatic Failure: 10 people, 13.70%
Loss Of Consciousness: 10 people, 13.70%
Febrile Neutropenia (fever with reduced white blood cells): 9 people, 12.33%
Thrombocytopenia (decrease of platelets in blood): 9 people, 12.33%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 23 people, 31.51%
Nausea (feeling of having an urge to vomit): 13 people, 17.81%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 8 people, 10.96%
Burkitt Lymphoma (cancer of the lymphatic system): 7 people, 9.59%
Small Cell Lung Cancer Stage Unspecified (lung cancer in unknown stage): 6 people, 8.22%
Diarrhea: 6 people, 8.22%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 6 people, 8.22%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 8.22%
Febrile Neutropenia (fever with reduced white blood cells): 6 people, 8.22%
Constipation: 6 people, 8.22%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and have Hepatitis cholestatic?

- Check whether Hepatitis cholestatic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etoposide:

Etoposide (77,815 reports)

Browse all side effects of Etoposide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis cholestatic:

Hepatitis cholestatic (546 drugs)

Browse all the conditions that are associated with Hepatitis cholestatic:

Hepatitis cholestatic (824 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.